Integrated BioPharma, Inc.
INBP · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | 1.6% | 10.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | 10.4% | 11.1% | 9.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | – | 6.5% | 7.5% | 4.1% |
| Net Income | $0 | -$0 | $0 | $0 |
| % Margin | – | -1.3% | 4.4% | 0.9% |
| EPS Diluted | 0.004 | -0.006 | 0.019 | 0.004 |
| % Growth | 167.2% | -129.9% | 424.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |